Replies to post #363573 on Amarin Corp Plc (AMRN)

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[Anilkhera]

Thank you Raf!!

[TastyTheElf]

Did I win?

I was pretty close...

[couldbebetter]

Thanks Raf! That makes two "not bad" weeks in a row...
Hope we have seen the bottom in both scrip numbers and the stock price.

[rafunrafun]

Scripts for week ending December 17, 2021

Drug Industry TRx: +0.2% w/w

Vascepa
TRx 81,120; -2.4% (-1,955) w/w; -10.4% y/y
NRx 37,524; -0.4% (-165) w/w; -12.1% y/y
Ref 43,596; -3.9% (-1,791) w/w; -8.9% y/y

Lovaza (Generic & Brand)
TRx 64,844; -1.4% (-915) w/w; -7.4% y/y
NRx 32,930; +0.6% (+200) w/w; -12.7% y/y
Ref 31,914; -3.4% (-1,115) w/w; -1.1% y/y

Generic Vascepa
TRx 25,551; +6.9% (+1,651) w/w; As % of total V: 24.0%
NRx 14,429; +7.7% (+1,029) w/w; As % of total V: 27.8%
Ref 11,122; +5.9% (+622) w/w; As % of total V: 20.3%

Generic Vascepa by Manufacturer
Hikma - TRx 13,977 (+641); Generic share 54.7%; Total V share 13.1%
Hikma - TRx 11,574 (+1,009); Generic share 45.3%; Total V share 10.8%

Vascepa + Generic Vascepa
TRx 106,671; -0.3% (-305) w/w
NRx 51,953; +1.7% (+864) w/w
Ref 54,718; -2.1% (-1,169) w/w